Bristol Myers Squibb has grown revenue 2.9% a year over three years and 2.1% a year over five, with earnings per share compounding at 6.5%. Revenue growth, 3-year annual rate: +2.9% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +2.1%, growth has picked up over the last three years. Earnings per share, 3-year rate: +6.5%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

BMYBristol Myers Squibb

HealthcareUSD

$67.58

$41.6752 weeks$67.93

Is it growing?

Is BMY growing?

Bristol Myers Squibb has grown revenue 2.9% a year over three years and 2.1% a year over five, with earnings per share compounding at 6.5%.

+2.9%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +2.1%
Revenue growth, 5-year rate · +2.9% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +6.5%
Earnings per share, 3-year rate · revenue +2.9% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed